v3.26.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 27, 2026
Sep. 28, 2025
Sep. 27, 2026
Sep. 28, 2025
Cash flows from operating activities:        
Net income $ 862 $ 6,873 $ 18,767 $ 9,162
Adjustments to reconcile net income to net cash provided by operating activities:        
Stock-based compensation expense, net of amounts capitalized     63,176 45,133
Depreciation and amortization     7,687 2,586
Gain on early lease termination 0 (4,144) 0 (4,144)
Gain on sale of long-term investment 0 0 (6,423) 0
Allowance for credit losses and non-cash changes to reserves     5,900 994
Deferred income taxes     326 (306)
Discount accretion on investments and other     (705) (2,180)
Changes in assets and liabilities, net of effect of acquisitions:        
Accounts receivable, net     (21,568) (19,400)
Inventories     (12,531) (4,696)
Prepaid expenses and other assets     (4,745) (883)
Accounts payable     4,734 14,422
Deferred revenue     9,837 12,964
Accrued and other liabilities     (4,941) 5,300
Net cash provided by operating activities     59,514 58,952
Cash flows from investing activities:        
Purchases of property and equipment, including capitalized software     (8,947) (9,996)
Purchases of short-term investments     (108,797) (112,932)
Purchase of long-term investment     0 (12,500)
Acquisitions of businesses, net of cash acquired     (48,155) 0
Proceeds from maturities of short-term investments     64,989 105,000
Proceeds from sale of long-term investment     18,923 0
Net cash used in investing activities     (81,987) (30,428)
Cash flows from financing activities:        
Proceeds from employee stock plans     1,955 2,280
Repurchases of common stock     (44,415) (26,824)
Net cash used in financing activities     (42,460) (24,544)
Net increase (decrease) in cash, cash equivalents, and restricted cash     (64,933) 3,980
Cash, cash equivalents, and restricted cash, at beginning of period     146,440 82,032
Cash, cash equivalents, and restricted cash, at end of period 81,507 86,012 81,507 86,012
Reconciliation of cash, cash equivalents, and restricted cash to Consolidated Balance Sheets:        
Cash and cash equivalents 79,587 86,012 79,587 86,012
Restricted cash 1,920 0 1,920 0
Total cash, cash equivalents, and restricted cash 81,507 86,012 81,507 86,012
Non-cash investing activities:        
Purchases of property and equipment included in accounts payable and accrued liabilities     880 423
Stock-based compensation expense capitalized for software development $ 808 $ 533 $ 1,585 $ 1,402